Sohliya, A. E. L. “Revumenib: The Newly Approved Food Drug Administration Drug for the Treatment of Relapsed Acute Leukemia With a KMT2A Translocation”. International Journal of Research in Medical Sciences, vol. 13, no. 2, Jan. 2025, pp. 987-8, doi:10.18203/2320-6012.ijrms20250291.